Faith B Dickerson: Influence Statistics

Faith B Dickerson

Faith B Dickerson

Sheppard Pratt, Baltimore, MD | Sheppard Pratt, Baltimore, MD, USA | College of Medicine, University of Arizona, Tucson, AZ, USA | Sheppard Pratt, Baltimore, MD 21204, USA;, ...

Faith B Dickerson: Expert Impact

Concepts for which Faith B Dickerson has direct influence: Bipolar disorder , Mental illness , Cognitive functioning , Onset psychosis , Herpes simplex virus , Acute mania , Individuals schizophrenia .

Faith B Dickerson: KOL impact

Concepts related to the work of other authors for which for which Faith B Dickerson has influence: Bipolar disorder , Mental illness , Patients schizophrenia , Gut microbiota , Physical activity , Negative symptoms , Cognitive impairment .

KOL Resume for Faith B Dickerson

Year
2022

Sheppard Pratt, Baltimore, MD

College of Medicine, University of Arizona, Tucson, AZ, USA

2021

Stanley Research Program, Sheppard Pratt, Baltimore, MD, USA.

Sheppard Pratt (Dickerson, Katsafanas, Newman, Origoni, Rowe, Squire, Ziemann, Khushalani) and Johns Hopkins University School of Medicine (Yolken), Baltimore.

2020

Sheppard Pratt Health System, Towson, MD, United States

Stanley Division of Developmental Neurovirology, USA

2019

Stanley Research Program, Sheppard Pratt Health System, Baltimore, MD 21204, United States

Sheppard Pratt Health System, Baltimore, MD, USA.

2018

Department of Psychology and.

Stanley Research Program, Sheppard Pratt Health System, Baltimore, MD 21204, USA

2017

Sheppard Pratt Hospital

2016

e Department of Pediatrics , Johns Hopkins School of Medicine , Baltimore , MD , USA.

2015

Stanley Research Program, Sheppard Pratt, Baltimore, MD, USA

Sheppard Pratt Health System, Baltimore, MD, United States of America

2014

Stanley Research Program at Sheppard Pratt, Sheppard Pratt Health System (Drs Dickerson, Goga, and Khushalani and Mss Stallings, Origoni, Katsafanas, Savage, and Schweinfurth); and Stanley Division of Developmental Neurovirology, Department of Pediatrics, Johns Hopkins University School of Medicine (Dr Yolken), Baltimore, Maryland.

Department of Psychiatry, University of Maryland School of Medicine, Baltimore, MD, USA

Sheppard Pratt Health System, Baltimore, MD

2013

Sheppard and Enoch Pratt Hospital, Baltimore, Maryland, USA

Dr. Schroeder is with Schroeder Statistical Consulting LLC, Ellicott City, Maryland.

2012

The Stanley Research Program at Sheppard Pratt

Department of Pediatrics, Stanley Division, 600 N. Wolfe Street, Blalock 1105, Johns Hopkins University, Baltimore, MD 21287, USA

2011

*Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, MD; †VA Capitol Healthcare Network (VISN 5) Mental Illness Research, Education, and Clinical Center, Baltimore, MD; ‡Department of Psychiatry, University of Maryland School of Medicine, Baltimore, MD; and §Sheppard Pratt Health System, Baltimore, MD.

Sheppard Pratt, 6501 North Charles St., Baltimore, MD 21204, United States

2010

Stanley Research Program, Sheppard and Enoch Pratt Hospital, Baltimore, Maryland, United States

Sheppard Pratt, Baltimore, MD 21204, USA

2009

*Mood and Anxiety Program, Department of Psychiatry, University of Maryland School of Medicine, Baltimore, MD; †Stanley Division of Developmental Neurovirology, Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD; ‡Epidemiology and Preventive Medicine, University of Maryland School of Medicine, Baltimore, MD; §Stanley Research Center, Sheppard Pratt Health System, Baltimore, MD; and ¶Department of Family and Community Health, University of Maryland School of Nursing, Baltimore, MD.

Sheppard Pratt Health System, 6501 North Charles St., Baltimore, MD, 21204 USA

Prominent publications by Faith B Dickerson

KOL-Index: 15818 . OBJECTIVES: We investigated the effect of elevated levels of C-reactive protein (CRP) and exposure to Herpes simplex virus type 1 (HSV-1) on the severity of cognitive impairment in individuals with schizophrenia. METHODS: We measured the levels of CRP and of antibodies to HSV-1 in serum samples from 588 individuals with schizophrenia by enzyme immunoassay tests. Cognitive functioning was ...
Known for Cognitive Impairment | Herpes Simplex | Individuals Schizophrenia | Elevated Levels
KOL-Index: 14180 . BACKGROUND: In a previous investigation, we found an association between reduced cognitive functioning and the prevalence of antibodies to herpes simplex virus type 1 in individuals with schizophrenia. The current study was undertaken to determine if this association also occurs in individuals with bipolar disorder. METHODS: Cognitive functioning and serologic evidence of infection with ...
Known for Bipolar Disorder | Simplex Virus Type | Cognitive Functioning | Infection Herpes
KOL-Index: 14013 . OBJECTIVES: Bipolar disorder (BD) is frequently misdiagnosed as major depressive disorder (MDD), which may lead to inappropriate treatment and poor outcomes. This study aimed to compare demographic and clinical features between patients with MDD and those with BD, but being misdiagnosed as MDD, in China. METHODS: A total of 1487 patients diagnosed with MDD were consecutively evaluated in ...
Known for Bipolar Disorder | Major Depressive | Patients Mdd | Psychotic Symptoms
KOL-Index: 13227 . OBJECTIVE: This study examined the prevalence of cigarette smoking and the quantity of cigarettes consumed by individuals with schizophrenia or bipolar disorder and by those with no psychiatric disorder in the period 1999-2011. METHODS: A total of 991 individuals with schizophrenia, bipolar disorder, or no psychiatric illness provided information about their cigarette smoking at ...
Known for Cigarette Smoking | Bipolar Disorder | Individuals Schizophrenia | Psychiatric Illness
KOL-Index: 12713 . BACKGROUND: Overweight and obesity are epidemic among persons with serious mental illness, yet weight-loss trials systematically exclude this vulnerable population. Lifestyle interventions require adaptation in this group because psychiatric symptoms and cognitive impairment are highly prevalent. Our objective was to determine the effectiveness of an 18-month tailored behavioral ...
Known for Mental Illness | Loss Intervention | Behavioral Weight | 18 Months
KOL-Index: 12248 . BACKGROUND: Prior reports of decreased levels of essential fatty acids among schizophrenic patients have generated several hypotheses proposing inherent abnormalities in phospholipid and fatty acid metabolism and have provided the basis for treatment trials; however, these essential fatty acid aberrations may be attributable to uncontrolled factors, such as smoking, rather than ...
Known for Fatty Acid | Schizophrenic Patients | Schizoaffective Disorder | Dietary Intake
KOL-Index: 11859 . The Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS) and Treatment Units for Research on Neurocognition and Schizophrenia projects were designed to facilitate the development of new drugs for the treatment of cognitive impairments in people with schizophrenia. The MATRICS project identified three drug mechanisms of particular interest: dopaminergic, ...
Known for Galantamine Memantine | Cognition Schizophrenia | Cognitive Impairment | Approved Medications
KOL-Index: 11729 . Cognitive impairment is a core feature of schizophrenia. Previous studies have indicated that exposure to neurotropic infectious agents such as Herpes Simplex Virus type 1 may contribute to cognitive deficits and neuroanatomical abnormalities in individuals with schizophrenia. We examined the association between exposure to neurotropic infectious agents and cognitive function in 1308 ...
Known for Herpes Simplex Virus | Cognitive Deficits | Type 1 | Individuals Schizophrenia
KOL-Index: 11643 . The Schizophrenia Patient Outcomes Research Team (PORT) psychosocial treatment recommendations provide a comprehensive summary of current evidence-based psychosocial treatment interventions for persons with schizophrenia. There have been 2 previous sets of psychosocial treatment recommendations (Lehman AF, Steinwachs DM. Translating research into practice: the Schizophrenia Patient ...
Known for Psychosocial Treatment | Schizophrenia Port | Summary Statements | Token Economy
KOL-Index: 11554 . BACKGROUND: Bipolar disorder is associated with deficits in cognitive functioning. The etiology of cognitive impairment in bipolar disorder may relate to both genetic and environmental factors. A valine/methionine polymorphism of the catechol O-methyltransferase gene at amino acid 158 (COMT Val158Met polymorphism) has been identified as a risk factor for cognitive impairment in ...
Known for Cognitive Impairment | Bipolar Disorder | Val158met Polymorphism | Serological Evidence
KOL-Index: 11536 . Latent infection with neurotropic herpes viruses, such as herpes simplex virus, type 1 (HSV1), has been generally considered benign in most immunocompetent individuals except for rare cases of encephalitis. However, several recent studies have shown impaired cognitive functions among individuals with schizophrenia exposed to HSV1 compared with schizophrenia patients not exposed to HSV1. ...
Known for Cognitive Impairment | Simplex Virus | Hsv1 Exposure | Type 1
KOL-Index: 11426 . BACKGROUND: Increased immune sensitivity to gluten has been reported in schizophrenia. However, studies are inconsistent about this association. METHODS: The sample of 471 individuals included 129 with recent-onset psychosis, 191 with multi-episode schizophrenia, and 151 controls. Immunoglobulin (Ig)G and IgA antibodies to gliadin and to tissue transglutaminase, and IgG antibodies to ...
Known for Celiac Disease | Gluten Sensitivity | Onset Psychosis | Episode Schizophrenia
KOL-Index: 11375 . Cognitive dysfunction is an important feature of schizophrenia and bipolar disorder. There is uncertainty about the relative magnitude of cognitive deficits in these disorders. We evaluated a total of 446 individuals: 229 with schizophrenia, 117 with bipolar disorder, and 100 controls without a history of psychiatric disorder. All participants were administered the Repeatable Battery for ...
Known for Bipolar Disorder | Repeatable Battery | Cognitive Functioning | Neuropsychological Status
KOL-Index: 11283 . Increased rates of exposure to Toxoplasma gondii have been found in individuals with schizophrenia and bipolar disorder, but the association between Toxoplasma and cognitive functioning has not previously been examined. We measured IgG and IgM class antibodies to Toxoplasma in 408 nonelderly individuals with schizophrenia, 347 with bipolar disorder, and 352 nonpsychiatric controls. ...
Known for Bipolar Disorder | Cognitive Functioning | Toxoplasma Gondii | Nonpsychiatric Controls

Key People For Bipolar Disorder

Top KOLs in the world
#1
Eduardo Eduard
bipolar disorder cognitive impairment acute mania
#2
Robert M Post
bipolar disorder affective illness depressed patients
#3
Susan L McElroy
bipolar disorder binge eating bulimia nervosa
#4
Paul E Keck
bipolar disorder acute mania united states
#5
Joseph R Calabrese
bipolar disorder suicidal ideation rapid cycling
#6
Gary S Sachs
bipolar disorder rapid cycling acute mania

Sheppard Pratt, Baltimore, MD | Sheppard Pratt, Baltimore, MD, USA | College of Medicine, University of Arizona, Tucson, AZ, USA | Sheppard Pratt, Baltimore, MD 21204, USA;, faithbdickerson@gmail.com | Sheppard Pratt Health System, Baltimore, MD, USA